Reckitt Benckiser notified the FDA that the company is voluntarily discontinuing the supply of Suboxone (buprenorphine and naloxone sublingual tablets).

The Federal Circuit’s decision vacates the District Court’s preliminary injunction that had prohibited Dr. Reddy’s from selling its generic version of Suboxone ® (buprenorphine and naloxone ...

Amneal Pharmaceuticals announced that the FDA has approved Buprenorphine HCl and Naloxone HCl Dihydrate Sublingual Tablets, the generic version of Reckitt Benckiser's Suboxone.

Hi-Tech announced that it would market buprenorphine hydrochloride in the 2-mg and 8-mg strengths through its Midlothian Labs division. The drug is in the form of a tablet placed under the tongue.